Glycorex Transplantation AB (GTAB): Interim Report April-June 2021
Net sales increased 143% and significantly improved operating income.April – June 2021 (compared to the corresponding period last year) · Net sales: SEK 8,0 million (3,3). · Operating income: SEK -2,2 million (-6,4). · Net income for the period: SEK -2,3 million (-6,8). · Earnings per share: SEK -0,03 (-0,09), no dilution effects. · COVID-19 reorientation support SEK 0,85 million received. · Positive trend and good sales growth in the majority of the company's markets, including record sales to Spain and 74 percent growth in the company's largest market Germany.